1. Home
  2. FULC vs BGS Comparison

FULC vs BGS Comparison

Compare FULC & BGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.50

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

Logo B&G Foods Inc.

BGS

B&G Foods Inc.

HOLD

Current Price

$3.94

Market Cap

445.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULC
BGS
Founded
2015
1996
Country
United States
United States
Employees
N/A
86
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
467.8M
445.5M
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
FULC
BGS
Price
$3.50
$3.94
Analyst Decision
Buy
Hold
Analyst Count
8
5
Target Price
$16.38
$4.90
AVG Volume (30 Days)
3.3M
1.8M
Earning Date
04-27-2026
05-12-2026
Dividend Yield
N/A
14.34%
EPS Growth
N/A
83.02
EPS
N/A
N/A
Revenue
N/A
$1,828,687,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.83
$3.67
52 Week High
$15.74
$6.38

Technical Indicators

Market Signals
Indicator
FULC
BGS
Relative Strength Index (RSI) 34.50 43.30
Support Level $2.83 $3.81
Resistance Level $4.02 $4.64
Average True Range (ATR) 0.23 0.12
MACD 0.10 0.02
Stochastic Oscillator 13.11 39.76

Price Performance

Historical Comparison
FULC
BGS

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About BGS B&G Foods Inc.

B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.

Share on Social Networks: